“…PAOxs offer a large structural variability and associated variation in polymer properties for the construction of polymer material for biological and pharmaceutical applications, driven by their unique features, such as non-ionic nature, hydrophilicity, tunable thermal, solution and chemical properties along with high biocompatibility and stealth characteristics. Therefore, PAOxs have gained significant interest for various pharmaceutical and biomedical applications such as matrix excipients for oral drug formulation, 110,111 self-assembled nanocarriers/polymersomes for drug delivery, [112][113][114] polymer-protein [115][116][117] and polymer-drug conjugates, 118,119 anti-bacterial and anti-microbial agents, 82,83 anti-fouling surfaces, 120,121 and hydrogels and nanogels for drug/gene delivery. [122][123][124] Since the discovery of PAOx in 1966, the syntheses of more than 125 PAOx homopolymers with various side chain functionalities have been reported in the literature, either via CROP of newly designed 2-oxazoline monomers or through post-polymerization modification methods.…”